Aether Bio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
2ndary - Private
- Investors
-
20
Aether Bio General Information
Description
Developer of a biocatalyst engineering technology designed to repurpose enzymes to create a new compound. The company's technology utilizes machine learning combined with high-throughput robotic laboratories to engineer enzymes rapidly and allows massively parallelized experimentation, generating datasets orders of magnitude larger, enabling researchers to manufacture complex and novel medical products at a fraction of the cost.
Contact Information
Website
www.aetherbio.comCorporate Office
- 1455 Adams Drive
- Suite 1630
- Menlo Park, CA 94025
- United States
Corporate Office
- 1455 Adams Drive
- Suite 1630
- Menlo Park, CA 94025
- United States
Aether Bio Timeline
Aether Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 5. Later Stage VC (Series A2) | 03-Dec-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 16-Aug-2023 | Completed | Generating Revenue | |||
| 3. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | $9.9M | Completed | Generating Revenue | |||
| 1. Early Stage VC | 26-Nov-2018 | $9.9M | $9.9M | Completed | Generating Revenue |
Aether Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-104 | ||||||||
| Series A-103 | ||||||||
| Series A-102 | ||||||||
| Series A-101 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed 1 | 176,470 | $0.000010 | $0.17 | $0.17 | 1x | $0.17 | 0.19% | |
| Seed | 5,204,203 | $0.000010 | $2.67 | $2.67 | 1x | $2.67 | 5.66% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aether Bio Patents
Aether Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4743786-A1 | Use of generative artificial intelligence for protein engineering | Pending | 13-Jul-2023 | ||
| WO-2025014634-A1 | Use of generative artificial intelligence for protein engineering | Inactive | 13-Jul-2023 | ||
| EP-4463546-A2 | Systems and methods for engineering protein activity | Pending | 10-Jan-2022 | ||
| EP-4463546-A4 | Systems and methods for engineering protein activity | Pending | 10-Jan-2022 | ||
| US-20240013854-A1 | Systems and methods for engineering protein activity | Pending | 10-Jan-2022 | G16B40/20 |
Aether Bio Signals
Aether Bio Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 4DX Ventures | Venture Capital | Minority | ||
| Contrary (San Francisco) | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| House Capital | Venture Capital | Minority | ||
| Modi Ventures | Venture Capital | Minority |
Aether Bio FAQs
-
When was Aether Bio founded?
Aether Bio was founded in 2017.
-
Where is Aether Bio headquartered?
Aether Bio is headquartered in Menlo Park, CA.
-
What is the size of Aether Bio?
Aether Bio has 38 total employees.
-
What industry is Aether Bio in?
Aether Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Aether Bio a private or public company?
Aether Bio is a Private company.
-
What is Aether Bio’s current revenue?
The current revenue for Aether Bio is .
-
How much funding has Aether Bio raised over time?
Aether Bio has raised $73.9M.
-
Who are Aether Bio’s investors?
4DX Ventures, Contrary (San Francisco), Gaingels, House Capital, and Modi Ventures are 5 of 20 investors who have invested in Aether Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process